25 April 2019
Farrer Kane appointed to raise profile of medical device company Medovate
Communications agency Farrer Kane today announced that medtech innovator Medovate has brought them on board to provide PR advice.
Medovate is a medical device company dedicated to the development and commercialisation of innovative medtech created within the NHS. Medovate identifies high potential medtech innovations, providing specialist help and resources to support development through clinical trials, regulatory approval and market launch.
Farrer Kane will be providing media relations and event support for Medovate, as well as promoting the launch of a number of ground-breaking medtech products the company is currently developing.
Stuart Thomson, Managing Director, Medovate, said: "Farrer Kane's strong relationships with media across a wide spectrum of national and technical press in the healthcare and technology sectors will be invaluable as we grow our business. We know they have experience of successfully launching products internationally and feel confident they are the right team to support our business as we bring exciting new medtech innovations to the market."
Clo Davey, Associate Director at Farrer Kane, commented: "From solutions to make intensive care practices more efficient to life-saving surgical products, Medovate is creating medical technologies that truly make a difference to both patients' lives and the healthcare practitioners that use them. Medtech is a healthcare sector which is growing exponentially - and Medovate has a wealth of experience managing new products from concept, through to market launch, successful adoption and global acquisition. We are thrilled to be working with a company that is making a difference in the NHS, and look forward to highlighting the fantastic work that they do."